抗动脉粥样硬化药物的研究进展

s a life-threatening cardiovascular disease, atherosclerosis attracts more and more attention. Medicines to lower lipid level, to lessen oxidants and to inhibit platelet aggregation are commonly used to treat atherosclerosis. With better understanding the pathogenesis of atherosclerosis, new types of medicines come to clinical trial, including inhibitors to target proprotein convertase subtilisin/kexin type 9, microsomal transfer protein inhibitors and gene therapy. This review summarizes the progress of anti-atherosclerotic medicines.